2005
DOI: 10.1365/s10337-005-0629-1
|View full text |Cite
|
Sign up to set email alerts
|

Development and Validation of a High Performance Liquid Chromatographic Method for the Determination of Voriconazole Content in Tablets

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
18
1

Year Published

2008
2008
2018
2018

Publication Types

Select...
10

Relationship

0
10

Authors

Journals

citations
Cited by 18 publications
(19 citation statements)
references
References 10 publications
0
18
1
Order By: Relevance
“…18,19 Practicing pharmacists should exercise caution when preparing extemporaneous voriconazole preparations that may result in the final products having an alkaline pH.…”
Section: Discussionmentioning
confidence: 99%
“…18,19 Practicing pharmacists should exercise caution when preparing extemporaneous voriconazole preparations that may result in the final products having an alkaline pH.…”
Section: Discussionmentioning
confidence: 99%
“…[25][26][27] The HPLC system consisted of a Waters 717 Plus autosampler, a Waters 1515 Isocratic HPLC pump (Waters Corporation, Milford, MA, USA), and a Gilson 117 UV-Visible detector (Gilson, Middleton, WI, USA). Separation was achieved with a Zorbax 300 SB, C8 Stable Bond, 5-lm, 150-mm 3 4.6-mm chromatographic column (Agilent Technologies, Santa Clara, CA, USA), protected by a Zorbax SB C8, 5-lm, 12.5-mm 3 4.6-mm guard cartridge (Agilent).…”
Section: Sample Analysismentioning
confidence: 99%
“…Voriconazole is commercially available in two strengths, 50 mg and 200 mg, with the brand name VFend (Pfizer, Inc.). So far, some liquid chromatographic procedures have been described for the determination of Voriconazole in tablet dosage form [1–4, 9, 10]. The HPLC method is used for the quantification of Voriconazole in plasma [5].…”
Section: Introductionmentioning
confidence: 99%